Efficacy and safety of certolizumab pegol induction therapy in an unselected Crohn's disease population: Results of the FACTS survey†
暂无分享,去创建一个
G. Rogler | A. Schoepfer | A. Straumann | S. Vavricka | F. Seibold | C. Felley | P. Michetti | B. Sauter | P. de Saussure | J. Binek | M. Geyer | M. Manz